Special clinical interest in prostate cancer.
Professor Thomas Eade returned to Australia in January 2007, after time spent working as the Thomas Baker Fellow at the Fox Chase Cancer Center in Philadelphia, USA. Fox Chase, which specialises in the treatment of prostate cancer, is one of the leading Radiation Oncology Centres in the USA. While in America, A/Professor Eade trained in the latest radiation therapy techniques, including IMRT, intraoperative real-time seed brachytherapy and high dose rate brachytherapy.
A/Professor Eade is now recognised across the country for his expertise in the IMRT/VMAT and IGRT techniques for the treatment of prostate cancer. A/Professor Eade has pioneered some of the most advanced prostate cancer ‘external beam’ treatments in Australia. In 2008, A/Professor Eade also established a permanent seed brachytherapy programme and high dose rate brachytherapy programme.A/Professor Eade is also one of a few specialists in Australia able to offer intraoperative real time seed brachytherapy treatment for prostate cancer. A/Professor Eade has been a guest speaker at state, national and international meetings on advanced radiation techniques.
In addition to his strong patient care and outcome focus, A/Professor Eade is also a committed researcher. A/Professor Eade is the Director of Research in the Northern Sydney Cancer Centre and also developed the prospective database for prostate cancer radiotherapy, which is in use across the North Shore and Central Coast campus. A key area of interest for A/Professor Eade is in researching and evaluating the delivery of new technology in radiotherapy. He is the Principle Investigator for the first Australian study of Stereotactic Radiotherapy (five treatments) for prostate cancer, which is currently recruiting (HEAT study).
A/Professor Eade has authored articles on dose escalation and IMRT for prostate cancer publications in major international oncology journals.